Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib (rcc)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2009 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00890110
First received: April 26, 2009
Last updated: April 28, 2009
Last verified: April 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)